Table 1.
GEO series | Experiment | Platform | Overall design |
---|---|---|---|
GSE164760 | Bulk RNA-seq | GPL13667 | 74 NASH livers, 8 cirrhotic livers, and 6 healthy livers |
GSE89632 | Bulk RNA-seq | GPL14951 | 19 NASH livers, 20 steatotic livers, and 24 healthy livers |
GSE49541 | Bulk RNA-seq | GPL570 | 40 mild fibrotic NASH liver and 32 advaced fibrotic NASH |
GSE139602 | Bulk RNA-seq | GPL13667 | 5 fibrosis (eCLD), 8 compensated cirrhosis, 12 decompensated cirrhosis, 8 ACLF, and 6 control healthy livers |
GSE123661 | scRNA-seq | GPL17303 | 4 cirrhotic and 5 healthy KC samples |
GSE136103 | scRNA-seq | GPL20301 | 5 healthy livers, 5 cirrhotic livers, and 4 PBMC samples |
GSE98782 | scRNA-seq | GPL17021 | 2 MoMFs and 2 KCs from chronic injured livers |